• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS FREE PSA; TEST,PROSTATE SPECIFIC ANTIGEN,FREE,(NONCOMPLEXED) TO DISTINGUISH PROSTATE CA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS FREE PSA; TEST,PROSTATE SPECIFIC ANTIGEN,FREE,(NONCOMPLEXED) TO DISTINGUISH PROSTATE CA Back to Search Results
Catalog Number 03289788190
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/17/2017
Event Type  malfunction  
Manufacturer Narrative
Unique identifier (udi)#: (b)(4).This event occurred in (b)(6).
 
Event Description
The customer experienced an issue where the elecsys free psa immunoassay results were higher than the elecsys total psa immunoassay results for two patients.The customer used the cobas 8000 e 602 module serial number (b)(4).For patient 1 the free psa result was 2.19 ng/ml and the total psa result was 0.07 ng/ml.For patient 2 on (b)(6) 2017 the free psa result was 3.7ng/ml and the total psa result was 0.065 ng/ml.On (b)(6) 2017 the patient 2 sample was repeated with an automatic dilution and the free psa result was 3.53 ng/ml.The patient 2 sample was tested using the siemens method and the free psa result was 0.02 ng/ml and the total psa result was 3.24 ng/ml.The customer believed the results from the siemens method.The results were reported outside of the laboratory.There was no allegation of an adverse event.This medwatch will cover the erroneous free psa results on the e 602 module.Patient identifier (b)(6) for information on the erroneous total psa results from the e 602 module.
 
Manufacturer Narrative
The patient samples were submitted for investigation.The customer¿s results of free psa and total psa are reproducible and their complaint has been confirmed.The erroneous result of total psa is caused by the presence of endogenous interfering substances affecting the epitope or the paratope of the biotinylated anti-psa antibody.Product labeling for total psa states "it is known that in rare cases psa isoforms do exist which may be measured differently by different psa tests.Findings of this kind have occasionally been reported for psa tests from various manufacturers.For diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings." investigation was performed by adding an additional biotinylated anti-psa antibody targeting another epitope.This approach gives a result for the free psa/total psa ratio of <1 in the investigated patient samples.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREE PSA
Type of Device
TEST,PROSTATE SPECIFIC ANTIGEN,FREE,(NONCOMPLEXED) TO DISTINGUISH PROSTATE CA
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key7133019
MDR Text Key96032290
Report Number1823260-2017-03051
Device Sequence Number1
Product Code MTG
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
P000027
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 01/18/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number03289788190
Device Lot Number20987700
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/11/2017
Initial Date FDA Received12/20/2017
Supplement Dates Manufacturer Received12/11/2017
Supplement Dates FDA Received01/18/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Age66 YR
-
-